Brad Crutchfield

Brad Crutchfield has extensive experience in the biotech industry. Brad is currently the Director at Partillion Bioscience. Prior to this, they served as a Board Member at Pixelgen Technologies. From 2017 to 2022, they held the position of Chief Commercial Officer at 10X Genomics. Before that, they worked as a Senior Vice President at QIAGEN from 2015 to 2017. Brad also served as Vice President and General Manager at Illumina in 2014 and as a Director at NanoString Technologies from 2013 to 2014. Brad started their career at Bio-Rad Laboratories in 2002 as a Vice President and later became the President of the Life Science Group. Overall, Brad has held various leadership roles in prominent biotech companies.

From 1980 to 1984, Brad Crutchfield attended the University of California, Davis, where they pursued a degree in physiology. No specific field of study is mentioned for this period.